Analyst stock forecast
Harmony Biosciences Holdings Forecast: $46.10 Analyst Target
HRMY has a $46.10 target, Buy rating and 10 analysts. As of 2026-08-23.
Direct answer
Harmony Biosciences Holdings's average price target is $46.10.
The target implies +20.8% from the recorded current price, and the consensus rating is Buy.
The low target implies -21.4%, the high target implies +83.5%, and the range spans 104.8% of the current price.
Forecast evidence checked August 23, 2026.
Get free Harmony Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $38.15
- Average price target
- $46.10
- High price target
- $70.00
- Low price target
- $30.00
- Low target gap
- -21.4%
- Target upside
- +20.8%
- High target gap
- +83.5%
- Target range width
- 104.8%
- Consensus rating
- Buy
- Analysts
- 10
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is Harmony Biosciences Holdings's average price target?
Harmony Biosciences Holdings's verified average price target is $46.10. The target range is $30.00 to $70.00.
How far are Harmony Biosciences Holdings's low and high targets from the recorded price?
The low target implies -21.4%, while the high target implies +83.5%.
How many analysts are included in Harmony Biosciences Holdings's consensus?
The verified consensus includes 10 analysts.
How is Harmony Biosciences Holdings's target upside or downside calculated?
The average target of $46.10 is divided by the recorded price of $38.15, then one is subtracted to produce +20.8%. This does not guarantee a future return.
When was Harmony Biosciences Holdings's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.